- Home
- FGEN vs CIF Comparison
FGEN vs CIF Comparison
Compare FGEN & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- CIF
- Stock Information
- Founded
- FGEN 1993
- CIF 1988
- Country
- FGEN United States
- CIF United States
- Employees
- FGEN N/A
- CIF N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- CIF Trusts Except Educational Religious and Charitable
- Sector
- FGEN Health Care
- CIF Finance
- Exchange
- FGEN Nasdaq
- CIF Nasdaq
- Market Cap
- FGEN 34.0M
- CIF 32.0M
- IPO Year
- FGEN 2014
- CIF N/A
- Fundamental
- Price
- FGEN $0.36
- CIF $1.72
- Analyst Decision
- FGEN
- CIF
- Analyst Count
- FGEN 0
- CIF 0
- Target Price
- FGEN N/A
- CIF N/A
- AVG Volume (30 Days)
- FGEN 1.5M
- CIF 43.9K
- Earning Date
- FGEN 11-12-2024
- CIF 01-01-0001
- Dividend Yield
- FGEN N/A
- CIF 10.11%
- EPS Growth
- FGEN N/A
- CIF N/A
- EPS
- FGEN N/A
- CIF N/A
- Revenue
- FGEN $180,015,000.00
- CIF N/A
- Revenue This Year
- FGEN $20.42
- CIF N/A
- Revenue Next Year
- FGEN N/A
- CIF N/A
- P/E Ratio
- FGEN N/A
- CIF N/A
- Revenue Growth
- FGEN 16.15
- CIF N/A
- 52 Week Low
- FGEN $0.18
- CIF $1.47
- 52 Week High
- FGEN $2.93
- CIF $1.77
- Technical
- Relative Strength Index (RSI)
- FGEN 50.21
- CIF 28.41
- Support Level
- FGEN $0.18
- CIF $1.71
- Resistance Level
- FGEN $0.43
- CIF $1.78
- Average True Range (ATR)
- FGEN 0.04
- CIF 0.02
- MACD
- FGEN 0.01
- CIF -0.00
- Stochastic Oscillator
- FGEN 66.94
- CIF 7.71
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.